Fouladi, M., Perentesis, J. P., Wagner, L. M., Vinks, A. A., Reid, J. M., Ahern, C., . . . Blaney, S. M. (2014). A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children’s Oncology Group Phase 1 Consortium Report. Clin Cancer Res.
Citação norma ChicagoFouladi, Maryam, et al. "A Phase I Study of Cixutumumab (IMC-A12) in Combination With Temsirolimus (CCI-779) in Children With Recurrent Solid Tumors: A Children’s Oncology Group Phase 1 Consortium Report." Clin Cancer Res 2014.
Citação norma MLAFouladi, Maryam, et al. "A Phase I Study of Cixutumumab (IMC-A12) in Combination With Temsirolimus (CCI-779) in Children With Recurrent Solid Tumors: A Children’s Oncology Group Phase 1 Consortium Report." Clin Cancer Res 2014.